Virtus LifeSci Profile

Performance

   

Odds of Distress

75%75%
Check how we calculate scores
Equity ratings for Virtus LifeSci Biotech Products are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 21, 2019 and ending today October 19, 2019. Click here to learn more.

Virtus LifeSci Profile

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Virtus LifeSci is traded on BATS Exchange in USA. more
NameVirtus LifeSci Biotech Products
Thematic Classification
Currently Active Investing Idea
  Healthcare Funds
View All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerVirtus
ExchangeBATS Exchange
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone888 383 0553
CurrencyUSD - US Dollar
IssuerVirtus
DescriptionVirtus LifeSci Biotech Products ETF
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Products Index
Entity TypeRegulated Investment Company
Asset Under Management25.36 Million
Average Trading Valume1,979.6
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Oct
ExchangeNYSE Arca
Number of Constituents42.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price36.23
Two Hundred Day Average39.41
Ytd2.76%
Average Daily Volume In Three Month3.77k
Fifty Two Week Low31.02
As Of DateSeptember 30, 2019
Average Daily Volume Last 10 Day1.74k
Fifty Two Week High46.39
One Month-3.73%
Fifty Day Average36.76
Three Month-12.66%
Virtus LifeSci Biotech Products [BBP] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. The entity is thematically classified as Healthcare Funds. Virtus LifeSci Biotech currently have 25.13 M in assets under management (AUM). , while the total return for the last 3 years was 2.5%.
Check Virtus LifeSci Probability Of Bankruptcy

Top Etf Constituents

Virtus LifeSci Target Price Odds Analysis

Odds Below 36.26HorizonTargetOdds Above 36.26
17.48%30 days 36.26 82.31%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is about 82.31 (This Virtus LifeSci Biotech Products probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Biotech Top Holders

Virtus LifeSci Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Carroll Financial Associates IncFund Units253K
View Virtus LifeSci Diagnostics

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Virtus LifeSci Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Virtus LifeSci price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Virtus LifeSci Key Fundamentals

Virtus LifeSci Against Markets

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Check also Trending Equities. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com